The chemical class known as PRSS39 Activators comprises a spectrum of compounds that can escalate the activity of PRSS39, a member of the serine protease family. These activators operate by engaging in various biochemical interactions that lead to the upregulation of PRSS39 activity, albeit through indirect pathways. Some activators within this class influence the cellular balance between proteases and their natural inhibitors, which can result in the upregulation of PRSS39 activity as a compensatory cellular response. This can occur through the inhibition of other proteases, thereby shifting the equilibrium and necessitating increased PRSS39 activity. Alternatively, molecules that modulate signaling pathways associated with the synthesis or regulation of proteases can also lead to an increase in PRSS39 activity. This modulation can prompt cellular mechanisms to enhance the expression or activity of PRSS39 to maintain homeostasis.
Within this class, activators can also affect the intracellular milieu in such a way that fosters an environment conducive to PRSS39 activation. For example, alterations in cellular ion concentrations or the inhibition of specific phosphatases can initiate a cascade of events that culminates in the activation of PRSS39. Enzymatic feedback loops are another target of PRSS39 Activators, wherein the inhibition of certain proteases triggers a response that results in the increased activity of PRSS39. Additionally, the alteration of protease zymogens into their active form can be a consequence of the action of PRSS39 Activators, further illustrating the diverse mechanisms through which these compounds can elevate the activity of PRSS39. This illustrates the multifaceted approach these activators take in modulating the activity of PRSS39, leveraging the intricate web of cellular processes that govern protease activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
AEBSF hydrochloride | 30827-99-7 | sc-202041 sc-202041A sc-202041B sc-202041C sc-202041D sc-202041E | 50 mg 100 mg 5 g 10 g 25 g 100 g | $65.00 $122.00 $428.00 $851.00 $1873.00 $4994.00 | 33 | |
An irreversible serine protease inhibitor that may upregulate PRSS39 expression as a compensatory response due to inhibition of related proteases. | ||||||
Gabexate mesylate | 56974-61-9 | sc-215066 | 5 mg | $100.00 | ||
A serine protease inhibitor; might enhance PRSS39 levels by triggering protease inhibitor responses. | ||||||
Nafamostat mesylate | 82956-11-4 | sc-201307 sc-201307A | 10 mg 50 mg | $82.00 $306.00 | 4 | |
A synthetic serine protease inhibitor that could lead to increased PRSS39 activity by competitive inhibition of other proteases, thereby redirecting substrates. | ||||||
Camostat mesylate | 59721-29-8 | sc-203867 sc-203867A sc-203867B sc-203867C sc-203867D sc-203867E | 10 mg 50 mg 500 mg 1 g 10 g 100 g | $43.00 $183.00 $312.00 $624.00 $2081.00 $4474.00 | 5 | |
A protease inhibitor that could upregulate PRSS39 through compensatory cellular mechanisms when other proteases are inhibited. | ||||||
Tranexamic acid | 1197-18-8 | sc-204921 sc-204921A | 5 g 10 g | $29.00 $50.00 | 10 | |
An antifibrinolytic that could increase PRSS39 activity indirectly due to the broad modulation of the protease-antiprotease balance. | ||||||
Leupeptin hemisulfate | 103476-89-7 | sc-295358 sc-295358A sc-295358D sc-295358E sc-295358B sc-295358C | 5 mg 25 mg 50 mg 100 mg 500 mg 10 mg | $73.00 $148.00 $316.00 $499.00 $1427.00 $101.00 | 19 | |
A thiol protease inhibitor that, through inhibitory feedback, could lead to upregulation or activation of serine proteases including PRSS39. | ||||||
Aprotinin | 9087-70-1 | sc-3595 sc-3595A sc-3595B | 10 mg 100 mg 1 g | $112.00 $408.00 $3000.00 | 51 | |
A polypeptide inhibitor of several serine proteases that could cause an increase in PRSS39 activity by feedback regulation mechanisms. | ||||||
E-64 | 66701-25-5 | sc-201276 sc-201276A sc-201276B | 5 mg 25 mg 250 mg | $281.00 $947.00 $1574.00 | 14 | |
An irreversible cysteine protease inhibitor that may indirectly upregulate serine proteases such as PRSS39 as part of a broader cellular response. | ||||||